{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:33:58Z","timestamp":1793226838027,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.jp","jtcvsopen.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JTCVS Open"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.xjon.2026.101830","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T16:09:27Z","timestamp":1776701367000},"page":"101830","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Increasing time-to-treatment for resectable non\u2013small cell lung cancer: Predictors and survival impact"],"prefix":"10.1016","volume":"32","author":[{"given":"Manzar","family":"Abbas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5826-7638","authenticated-orcid":false,"given":"Dean","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kostantinos","family":"Poulikidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Jawad","family":"Latif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiz Y.","family":"Bhora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.xjon.2026.101830_bib2","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.athoracsur.2022.06.016","article-title":"Increasing time-to-treatment for lung cancer: are we going backward?","volume":"115","author":"Muslim","year":"2023","journal-title":"Ann Thorac Surg"},{"issue":"10","key":"10.1016\/j.xjon.2026.101830_bib4","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1001\/jama.2021.1117","article-title":"Screening for lung cancer: US preventive services task force recommendation statement","volume":"325","author":"Krist","year":"2021","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.xjon.2026.101830_bib5","doi-asserted-by":"crossref","first-page":"8677","DOI":"10.3390\/curroncol29110684","article-title":"The impact of COVID-19 on the diagnosis and treatment of lung cancer over a 2-year period at a Canadian academic center","volume":"29","author":"Kasymjanova","year":"2022","journal-title":"Curr Oncol"},{"issue":"1","key":"10.1016\/j.xjon.2026.101830_bib6","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/s12890-024-03082-x","article-title":"Diagnostic and therapeutic delays in lung cancer during the COVID-19 pandemic: a single center experience at a German cancer center","volume":"24","author":"Tarawneh","year":"2024","journal-title":"BMC Pulm Med"},{"issue":"6","key":"10.1016\/j.xjon.2026.101830_bib7","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.jtcvs.2024.11.040","article-title":"Time to surgery in early-stage non\u2013small cell lung cancer: defining the optimal diagnosis-to-resection interval to reduce mortality","volume":"169","author":"Tupper","year":"2025","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"5","key":"10.1016\/j.xjon.2026.101830_bib8","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.athoracsur.2025.04.018","article-title":"Association between social vulnerability index and time to treatment in resectable non\u2013small cell lung cancer","volume":"120","author":"Khan","year":"2025","journal-title":"Ann Thorac Surg"},{"issue":"7","key":"10.1016\/j.xjon.2026.101830_bib9","article-title":"Novel approach to proficiency testing reveals significant variations in biomarker practice leading to critical differences in lung cancer management","volume":"6","author":"Bisson","year":"2025","journal-title":"JTO Clin Res Rep"},{"issue":"3","key":"10.1016\/j.xjon.2026.101830_bib10","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.3390\/curroncol31030115","article-title":"Biomarker turnaround times and impact on treatment decisions in patients with advanced non-small cell lung carcinoma at a large Canadian community hospital with an affiliated regional cancer centre","volume":"31","author":"Fleming","year":"2024","journal-title":"Curr Oncol"},{"issue":"3","key":"10.1016\/j.xjon.2026.101830_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0213209","article-title":"Time to initial cancer treatment in the United States and association with survival over time: an observational study","volume":"14","author":"Khorana","year":"2019","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.xjon.2026.101830_bib12","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.healthpol.2021.06.004","article-title":"Is time-to-treatment associated with higher mortality in Korean elderly lung cancer patients?","volume":"125","author":"Han","year":"2021","journal-title":"Health Policy"},{"key":"10.1016\/j.xjon.2026.101830_bib13","article-title":"Mortality due to cancer treatment delay: systematic review and meta-analysis","volume":"371","author":"Hanna","year":"2020","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.xjon.2026.101830_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e19750","article-title":"Impact of time-to-treatment initiation on survival in single primary non\u2013small cell lung cancer: a population-based study","volume":"9","author":"Teng","year":"2023","journal-title":"Heliyon"},{"issue":"8","key":"10.1016\/j.xjon.2026.101830_bib15","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.annonc.2020.05.009","article-title":"Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic","volume":"31","author":"Sud","year":"2020","journal-title":"Ann Oncol"},{"issue":"17","key":"10.1016\/j.xjon.2026.101830_bib16","doi-asserted-by":"crossref","DOI":"10.1111\/1759-7714.70163","article-title":"Clinical significance of time-to-surgery and COVID-19 pandemic in surgically treated non\u2013small cell lung cancer","volume":"16","author":"Ghimessy","year":"2025","journal-title":"Thorac Cancer"},{"issue":"2","key":"10.1016\/j.xjon.2026.101830_bib17","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.radonc.2015.04.010","article-title":"Time to treatment as a quality metric in lung cancer: staging studies, time to treatment, and patient survival","volume":"115","author":"Gomez","year":"2015","journal-title":"Radiother Oncol"},{"issue":"11","key":"10.1016\/j.xjon.2026.101830_bib18","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1097\/JTO.0b013e3181bbb130","article-title":"Lung cancer diagnostic and treatment intervals in the United States: a health care disparity?","volume":"4","author":"Yorio","year":"2009","journal-title":"J Thorac Oncol"},{"issue":"12","key":"10.1016\/j.xjon.2026.101830_bib19","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.50237","article-title":"Comparison of capture rates of the national cancer database across race and ethnicity","volume":"6","author":"Satpathy","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.xjon.2026.101830_bib20","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b5087","article-title":"Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes","volume":"340","author":"L\u00e9vesque","year":"2010","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.xjon.2026.101830_bib21","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.athoracsur.2024.01.004","article-title":"Neoadjuvant vs adjuvant chemoimmunotherapy for stage II-IIIB non\u2013small cell lung cancer","volume":"118","author":"Martins","year":"2024","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.xjon.2026.101830_bib22","article-title":"Improving community care lung cancer screening by implementation of centralized support: a quality improvement initiative","volume":"21","author":"Hirsch","year":"2026","journal-title":"Ann Am Thorac Soc"}],"container-title":["JTCVS Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666273626002536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666273626002536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:15:07Z","timestamp":1793225707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666273626002536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":20,"alternative-id":["S2666273626002536"],"URL":"https:\/\/doi.org\/10.1016\/j.xjon.2026.101830","relation":{},"ISSN":["2666-2736"],"issn-type":[{"value":"2666-2736","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increasing time-to-treatment for resectable non\u2013small cell lung cancer: Predictors and survival impact","name":"articletitle","label":"Article Title"},{"value":"JTCVS Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xjon.2026.101830","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Association for Thoracic Surgery.","name":"copyright","label":"Copyright"}],"article-number":"101830"}}